Reclaiming Treatment Success in Atopic Dermatitis:Patients Matter Most In the evolving landscape of atopic dermatitis (AD) therapeutics, we are witnessing a striking paradox: never have so many therapies been available, yet patient dissatisfaction remains high. Why? Because the metrics guiding clinical trials and regulatory approvals often diverge sharply from what patients truly value. A rigid […]
Read More
AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
The ISAD supports GADA’s initiative to collect global epidemiological data using appropriate instruments, which are not always readily available. This real-world data initiative should be encouraged, particularly given the significant information gaps in countries and regions with limited medical infrastructure. If you are interested in participating, please visit https://qualtrics.kcl.ac.uk/ On behalf of the Global Atopic […]
Read More
Different faces, shared targets: the curious convergence of AD, AA, and vitiligo In the evolving landscape of dermatology and clinical immunology, a compelling paradox is emerging: three phenotypically distinct conditions—atopic dermatitis (AD), alopecia areata (AA), and vitiligo—are increasingly found to share overlapping immunological features and respond to similar targeted therapies. Historically, the connections among these […]
Read MoreAD hidden hematologic risk: clonal hematopoiesis of indeterminate potential (CHIP) + An unusual facial bump related to AD + Switching off selectively skin lipid synthesis: a reversible human model of ceramide depletion + Beyond the skin: suicidal risk is real in AD + Complement, an overlooked driver of Th2 Immunity in AD
Read More
The success of the inaugural call for the ISAD-GADA Fellowship was highlighted, with nine applicants from nine different countries (Ethiopia, Tanzania, South Africa, Brazil, the Philippines, Nepal, Nigeria, China, and Uganda). A heartfelt thank you to everyone who applied. We were genuinely encouraged by the volume and quality of submissions we received. We are delighted […]
Read More
We are inviting abstract submissions for the 15th Georg RAJKA International Symposium on Atopic Dermatitis (ISAD), Melbourne 2025. Abstracts for oral and poster presentations will represent the core of the scientific program at this meeting. Abstracts pertaining to human atopic dermatitis and related fields including animal models are appropriate. Info: The Call for Abstracts is […]
Read More
Atopic Dermatitis with focus on Sub-Saharan Africa: Training for national and district-level health workers To access the course, you can either use this link https://whoacademy.org/ or type the course title in the search space. To enroll in the course, you will need to create an account if you have not already done so. Atopic dermatitis is […]
Read More
Research Trends in Epidemiology and Genetics of Atopic Dermatitis The Rise of Atopic Dermatitis in the Elderly Population Until the early 2000s, atopic dermatitis (AD) was primarily considered a pediatric condition. In older adults, a diagnosis of AD was often dismissed due to its perceived low incidence and frequently misclassified as senile pruritus, pre-bullous pemphigoid, […]
Read MoreHow COVID Quarantine May Have Fueled Infantile AD + Hidden Signs of Pruritus in Infants with AD + From Modeling Temperature Fluctuations to Blocking TRPV1: Restoring the Skin Barrier and Treating Pruritus + Can Early Short-Term Moisturizer Use Rewrite an Infant’s Microbiome and Prevent Atopic Dermatitis? + Serine Sensing System for tracking moisturizer treatment of a patient with AD
Read More